southphos aluminium phosphide tablets
envirofume limited - aluminium phosphide - aluminium phosphide 570 g/kg - insecticide
velphoro sucroferric oxyhydroxide 2500 mg (equivalent to iron 500 mg) chewable tablet bottle
seqirus pty ltd - sucroferric oxyhydroxide, quantity: 2500 mg - tablet, chewable - excipient ingredients: colloidal anhydrous silica; neohesperidin-dihydrochalcone; magnesium stearate; flavour - velphoro is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease (ckd) on dialysis.
velphoro sucroferric oxyhydroxide 2500 mg (equivalent to iron 500 mg) chewable tablet blister
seqirus pty ltd - sucroferric oxyhydroxide, quantity: 2500 mg - tablet, chewable - excipient ingredients: colloidal anhydrous silica; neohesperidin-dihydrochalcone; magnesium stearate; flavour - velphoro is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease (ckd) on dialysis.
contrave 8/90
inova pharmaceuticals (new zealand) limited - bupropion hydrochloride 90mg equivalent to bupropion 78mg; ; ; naltrexone hydrochloride 8mg equivalent to naltrexone 7.2mg; - modified release tablet - active: bupropion hydrochloride 90mg equivalent to bupropion 78mg naltrexone hydrochloride 8mg equivalent to naltrexone 7.2mg excipient: colloidal silicon dioxide crospovidone cysteine hydrochloride monohydrate disodium edetate hyprolose hypromellose indigo carmine aluminium lake lactose lactose monohydrate magnesium stearate microcrystalline cellulose opadry blue 85f90663 - contrave is indicated, as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients (>/= 18 years) with an initial body mass index (bmi) of: · >/= 30 kg/m2 (obese), or · >/= 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of one or more weight-related co-morbidities (e.g., type 2 diabetes, dyslipidaemia, or controlled hypertension). treatment with contrave should be discontinued after 16 weeks if patients have not lost at least 5% of their initial body weight.
anhydrol forte
trupharm marketing 1985 ltd. - aluminium chloride hexahydrate - solution - aluminium chloride hexahydrate 20 %w/v - aluminium chlorohydrate - aluminium chlorohydrate - for the topical treatment of hyperhydrosis specifically involving axillae, hands or feet.
aluminium phosphide
national fumigants pty ltd - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent
aluminium phosphide
adama australia pty limited - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent
aluminium phosphide
redox limited - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent
aluminium phosphide
imtrade australia pty ltd - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent
aluminium phosphide
parsram exporters pty ltd - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent